Invention Grant
US07691999B2 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
有权
RNA干扰介导使用短干扰核酸（siNA）抑制NOGO和NOGO受体基因表达
- Patent Title: RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
- Patent Title (中): RNA干扰介导使用短干扰核酸（siNA）抑制NOGO和NOGO受体基因表达
-
Application No.: US12174526Application Date: 2008-07-16
-
Publication No.: US07691999B2Publication Date: 2010-04-06
- Inventor: James McSwiggen , Leonid Beigelman
- Applicant: James McSwiggen , Leonid Beigelman
- Applicant Address: US CA San Francisco
- Assignee: Sirna Therapeutics, Inc.
- Current Assignee: Sirna Therapeutics, Inc.
- Current Assignee Address: US CA San Francisco
- Agent Elaine C. Stracker
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; A61K31/70
Abstract:
This invention relates to compounds, compositions, and methods useful for modulating NOGO and/or NOGO receptor gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of NOGO and/or NOGO receptor gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of NOGO and/or NOGO receptor genes, such as NOGO-A, NOGO-B, NOGO-C, NOGO-66 receptor, NI-35, NI-220, NI-250, myelin-associated glycoprotein, tenascin-R, and NG-2.
Public/Granted literature
Information query
